Now that is a high-impact policy change, if the FDA maintains their position.
U.S. health officials inject new uncertainty into approval process for Covid boosters | 

STAT
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible implications for Pf...
